Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	139.34	128.49	120.36	94.41	74.52	48.45
Depreciation & Amortization	124.37	123.17	102.71	89.99	81.8	84.07
Stock-Based Compensation	43.34	43.46	28.47	21.33	18.04	16.09
Other Adjustments	7.17	25.6	6.21	9.44	11.33	16.46
Change in Receivables	3.36	-2.97	-20.17	-9.49	-10.96	-19.04
Changes in Inventories	-33.66	-21.6	-2.29	-32.11	-47.93	-25.18
Changes in Accounts Payable	1.05	1.01	-2.31	-7.3	12.66	6.05
Changes in Accrued Expenses	1.74	14.26	9.72	-2.48	-16.38	36.46
Changes in Income Taxes Payable	10.77	5.31	-1.58	-1.69	4.48	0.2
Changes in Other Operating Activities	-3.69	-19.35	-20.31	-16.96	-13.27	-16.33
Operating Cash Flow	297.48	297.37	220.8	145.15	114.29	147.23
Operating Cash Flow Growth	32.12%	34.68%	52.12%	27.00%	-22.37%	-10.91%
Capital Expenditures	-76.66	-81.72	-35.14	-34.29	-45.03	-27.94
Sale of Property, Plant & Equipment	25.53	0.3	0.01	0.63	0.07	1.04
Purchases of Intangible Assets	-3.42	-3.12	-2.9	-2.41	-3.18	-2.83
Payments for Business Acquisitions	-144.77	-144.77	-320.18	-134.52	-6.88	-7.17
Proceeds from Business Divestments	0.12	-	-	-	-0.97	-
Other Investing Activities	-10.97	-18.08	-10.43	-4.76	-1.41	-0.25
Investing Cash Flow	-210.02	-247.39	-368.65	-175.35	-57.4	-37.16
Long-Term Debt Issued	-	-	-	1,199	215.21	98.42
Long-Term Debt Repaid	-	-	-99.06	-579.62	-260.14	-206.92
Net Long-Term Debt Issued (Repaid)	-	-	-99.06	619.58	-44.94	-108.5
Issuance of Common Stock	17.84	28.21	40.91	15.58	20.07	21.31
Net Common Stock Issued (Repurchased)	17.84	28.21	40.91	15.58	20.07	21.31
Other Financing Activities	-15.08	-12.21	-1.85	-75.9	-35.39	-11.24
Financing Cash Flow	2.76	16	-60.01	559.27	-60.26	-98.44
Effect of Exchange Rate Changes on Cash and Cash Equivalents	2.44	3.8	-2.52	-0.48	-3.83	-0.8
Net Cash Flow	92.65	69.78	-210.38	528.59	-7.19	10.83
Free Cash Flow	220.82	215.66	185.66	110.86	69.26	119.29
Free Cash Flow Growth	2.39%	16.16%	67.47%	60.06%	-41.94%	0.01%
FCF Margin	14.32%	14.23%	13.69%	8.82%	6.02%	11.10%
Free Cash Flow Per Share	3.67	3.57	3.13	1.90	1.20	2.08
Levered Free Cash Flow	163.26	149.57	72.09	709.15	5.92	-2.72
Unlevered Free Cash Flow	164.25	159.93	175.72	99.56	55.3	112.07

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q